School of Medicine


Showing 421-440 of 1,245 Results

  • Kate Hardy

    Kate Hardy

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 20 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy is the co-director for the INSPIRE clinic at the Department of Psychiatry and Behavioral Health, Stanford University and has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population and is the co-editor of the book Intervening Early: A team approach.

    Dr. Hardy is also the director of INSPIRE training and within this role has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. INSPIRE training offers training in evidence based interventions for psychosis to providers across diverse settings. In 2024 Dr. Hardy became president elect for IEPA: Intervening Early in Mental Health.

  • Earth Hasassri, MD

    Earth Hasassri, MD

    Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    BioDr. Earth Hasassri is an Adjunct Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry and Child Development, at Stanford University School of Medicine. He is dual board-certified in General Psychiatry and Child and Adolescent Psychiatry and maintains a private practice in Menlo Park, California. He is actively involved in teaching and mentoring medical students, residents, and fellows at Stanford.

    Dr. Hasassri specializes in the evaluation and treatment of children, adolescents, and adults with complex psychiatric and neuropsychiatric conditions, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, mood and anxiety disorders, obsessive-compulsive disorder (OCD), functional neurological disorders, and psychiatric conditions associated with neurological and other medical illnesses. His clinical approach integrates psychopharmacology, psychotherapy, and an understanding of the neurobiological underpinnings of psychiatric illness.

    His clinical and academic interests include interventional psychiatry, neuromodulation, and the application of neuroscience to personalized psychiatric treatment. He has a particular interest in transcranial magnetic stimulation (TMS), including accelerated treatment protocols and emerging approaches to individualized, circuit-based brain stimulation. He is especially interested in expanding the role of neuromodulation in treating complex and treatment-resistant psychiatric conditions and exploring its potential applications in child and adolescent psychiatry.

    Prior to medical school, Dr. Hasassri earned dual bachelor's degrees in Physiology and Neuroscience and Psychology from the University of California, San Diego, where he conducted research in sleep medicine. He received his medical degree from Mayo Clinic Alix School of Medicine, where he pursued research in clinical epidemiology. He subsequently completed his General Psychiatry Residency at the University of California, San Francisco (UCSF), where he was awarded an Area of Distinction in Clinical Neuroscience for his work integrating neuroscientific principles into the care of patients with brain tumors, dementia, neurodevelopmental disorders, and other neuropsychiatric conditions. He completed his Child and Adolescent Psychiatry Fellowship at Stanford University School of Medicine.

    Dr. Hasassri is certified by the American Board of Psychiatry and Neurology in both Psychiatry and Child and Adolescent Psychiatry. His work is guided by a commitment to advancing compassionate, evidence-based psychiatric care through the integration of clinical neuroscience, innovative treatments, and individualized approaches to mental health.

  • Nancy A. Haug

    Nancy A. Haug

    Adjunct Clinical Professor, Psychiatry and Behavioral Sciences

    BioNancy A. Haug, PhD is Adjunct Clinical Professor and Addiction Medicine fellowship program faculty in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She currently leads didactics and a journal club for Addiction Medicine fellows, and teaches a postdoctoral seminar on ethics and legal issues for the Clinical Psychology Fellowship Program. Dr. Haug's primary academic affiliation is Professor of Psychology at Palo Alto University, where she teaches, advises and supervises doctoral students in the PAU-Stanford PsyD Consortium. Dr. Haug previously served as faculty and attending psychologist in the Department of Psychiatry at the University of California San Francisco, and taught in the University of California, Berkeley Alcohol & Drug Studies program. She obtained her PhD in Clinical Psychology and Behavioral Medicine at the University of Maryland, Baltimore County and a Master's degree in Counseling Psychology at Loyola University, Maryland. She completed a clinical internship and postdoctoral fellowship at University of California, San Francisco and San Francisco General Hospital in public service and minority mental health.

    Dr. Haug chairs the American Psychological Association (APA) Ethics Committee and formerly served on the California Psychological Association Ethics Committee. She is a Fellow, Member-at-Large for Practice, and President- Elect of the Society of Addiction Psychology (Division 50). Dr. Haug is on the editorial board of the Journal of Psychoactive Drugs and the Journal of Addictive Diseases. She was funded by SAMHSA for a practitioner-education initiative to expand training for evidence-based addiction treatment. Dr. Haug leads the Harm Reduction and Addiction Treatment Laboratory at PAU with current research studies on the implementation of evidence-based practices in addiction treatment, harm reduction for substance use, cannabis vaping and psychedelic-assisted psychotherapy.

    Dr. Haug has been licensed as a psychologist in California since 2004, is board certified in addiction psychology by American Board of Professional Psychology, and has an independent practice in Los Gatos, CA. She has clinical expertise in treating substance misuse and eating disorders using motivational interviewing, cognitive-behavioral and mindfulness-based therapies including Acceptance and Commitment Therapy. Dr. Haug is a Stanford WellConnect referral for fellows, residents and faculty in her clinical practice. She completed the Stanford YogaX 200-Hour Yoga Teacher Training Program with healthcare setting emphasis.

  • John Lyon Havlik

    John Lyon Havlik

    Postdoctoral Medical Fellow, Psychiatry
    Resident in Psychiatry and Behavioral Sciences

    BioHello! I'm the inaugural Humanities and Social Medicine research track resident at Stanford University.

    Psychiatric and substance use disorders are usually caught only after substantial and sometimes irreparable harm has already occurred. My research program is focused on changing this in two ways. Number one, I build artificial intelligence models that identify people with psychiatric and substance use disorders earlier. I believe this kind of early intervention will one day be commonplace and prevent a great deal of human suffering. Number two, I evaluate whether the systems that receive them, like health plans, treatment facilities, and now generative AI chatbots, are equipped to respond appropriately. There is much work to do here.

    On the building side, I have developed a machine learning model that detects untreated substance use disorders from EHR-like data, published in Nature Mental Health; related work uses multimodal data to flag who will go on to develop substance use disorders and to predict imminent psychiatric emergency-department visits. I work across a wide range of deterministic and probabilistic methods, including the transformer architectures behind modern "chatbots." My work has been featured in 40+ peer-reviewed publications in venues such as Nature Medicine, NeurIPS, Science Advances, Nature Mental Health, JAMA Health Forum, and featured in national news outlets. But publications matter little to the lives of my patients. My aim is to develop models that are clinically useful. This aim has been met with some degree of success as spinout AI-enabled clinical workflow automation software I developed is in use at the U.S. Department of Veterans Affairs and here at Stanford.

    On the evaluating side, I serve as an expert reviewer of AI-in-medicine trials for the State of Utah's Office of Artificial Intelligence Policy, and I am a sought-after health-tech advisor for Silicon Valley's leading venture capital firms and companies. I write on psychiatric services and health policy, recently in JAMA Health Forum on private-equity residential treatment and JAMA Network Open on the economics of telemedicine "house calls". I also recently co-authored a Nature Medicine paper on how to rigorously test the true capabilities of medical AI and lead ongoing research in this area.

    Alongside my research, I have an enduring interest in medical education and founded and lead Research Roundtable, a psychiatric services research group whose undergraduates have published 10+ first-author papers. Before medicine, with Peggy Mason at UChicago, I found the human bystander effect in rats (Science Advances).

  • Chris Hayward

    Chris Hayward

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)

    Current Research and Scholarly InterestsDr. Hayward's research has focused on risk factors for the onset of adolescent internalizing disorders in adolescent girls and the role of early puberty specifically.

  • Alesha Heath

    Alesha Heath

    Basic Life Res Scientist, Psych/Public Mental Health & Population Sciences

    BioDr. Alesha Heath is a Postdoctoral Scholar at Psychiatry and Behavioral Sciences at Stanford School of Medicine and the MIRECC the VA Palo Alto. She earned her PhD from the University of Western Australia and Sorbonne University.

    Dr. Heath's research has been primarily focused on the mechanisms and applications of brain stimulation therapies, in particular repetitive transcranial magnetic stimulation. Her research involves both basic and clinical components with the aim of improving the efficacy of these therapies for the treatment of disorders such as depression and Alzheimer's disease.